Orthofix International N.V. (OFIX) Stake Lessened by Public Sector Pension investment Board

Public Sector Pension investment Board trimmed its holdings in Orthofix International N.V. (NASDAQ:OFIX) by 25.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,200 shares of the medical device company’s stock after selling 3,200 shares during the quarter. Public Sector Pension investment Board owned about 0.05% of Orthofix International N.V. worth $428,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in OFIX. Pinebridge Investments L.P. lifted its stake in shares of Orthofix International N.V. by 2.3% in the 2nd quarter. Pinebridge Investments L.P. now owns 2,378 shares of the medical device company’s stock valued at $111,000 after purchasing an additional 53 shares during the period. Mason Street Advisors LLC acquired a new position in shares of Orthofix International N.V. in the 1st quarter valued at about $159,000. State of Alaska Department of Revenue raised its stake in Orthofix International N.V. by 79.3% during the 2nd quarter. State of Alaska Department of Revenue now owns 3,551 shares of the medical device company’s stock worth $165,000 after buying an additional 1,571 shares during the period. BNP Paribas Arbitrage SA raised its stake in Orthofix International N.V. by 68.9% during the 1st quarter. BNP Paribas Arbitrage SA now owns 4,656 shares of the medical device company’s stock worth $178,000 after buying an additional 1,900 shares during the period. Finally, Municipal Employees Retirement System of Michigan acquired a new position in Orthofix International N.V. during the 2nd quarter worth approximately $196,000. 94.40% of the stock is currently owned by institutional investors.

Orthofix International N.V. (OFIX) opened at 49.02 on Wednesday. Orthofix International N.V. has a 1-year low of $32.51 and a 1-year high of $51.09. The company’s 50-day moving average price is $48.72 and its 200-day moving average price is $44.37. The firm has a market capitalization of $890.69 million, a P/E ratio of 114.80 and a beta of 0.20.

Orthofix International N.V. (NASDAQ:OFIX) last issued its quarterly earnings data on Monday, August 7th. The medical device company reported $0.42 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 9.96%. The business had revenue of $108.90 million during the quarter, compared to analyst estimates of $102.94 million. During the same period last year, the business posted $0.41 earnings per share. Orthofix International N.V.’s quarterly revenue was up 4.6% compared to the same quarter last year. Equities research analysts expect that Orthofix International N.V. will post $1.56 earnings per share for the current fiscal year.

A number of research firms recently weighed in on OFIX. Jefferies Group LLC reaffirmed a “buy” rating and set a $55.00 price target (up from $50.00) on shares of Orthofix International N.V. in a research note on Thursday, August 10th. BidaskClub downgraded Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Zacks Investment Research raised Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $54.00 price target on the stock in a research note on Thursday, August 10th. TheStreet raised Orthofix International N.V. from a “c+” rating to a “b-” rating in a research note on Tuesday, August 8th. Finally, Ladenburg Thalmann Financial Services began coverage on Orthofix International N.V. in a research note on Wednesday, June 14th. They set a “buy” rating and a $53.25 price target on the stock. Seven equities research analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and a consensus price target of $52.75.

ILLEGAL ACTIVITY NOTICE: “Orthofix International N.V. (OFIX) Stake Lessened by Public Sector Pension investment Board” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://ledgergazette.com/2017/10/11/orthofix-international-n-v-ofix-stake-lessened-by-public-sector-pension-investment-board.html.

In other news, CFO Rice Doug sold 7,353 shares of Orthofix International N.V. stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $49.46, for a total transaction of $363,679.38. Following the completion of the transaction, the chief financial officer now directly owns 44,743 shares in the company, valued at $2,212,988.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Brad Mason sold 2,733 shares of Orthofix International N.V. stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $48.10, for a total transaction of $131,457.30. Following the transaction, the chief executive officer now owns 188,053 shares of the company’s stock, valued at $9,045,349.30. The disclosure

Several other large investors have also made changes to their positions in OFIX. Pinebridge Investments L.P. lifted its stake in shares of Orthofix International N.V. by 2.3% in the 2nd quarter. Pinebridge Investments L.P. now owns 2,378 shares of the medical device company’s stock valued at $111,000 after purchasing an additional 53 shares during the period. Mason Street Advisors LLC acquired a new position in shares of Orthofix International N.V. in the 1st quarter valued at about $159,000. State of Alaska Department of Revenue raised its stake in Orthofix International N.V. by 79.3% during the 2nd quarter. State of Alaska Department of Revenue now owns 3,551 shares of the medical device company’s stock worth $165,000 after buying an additional 1,571 shares during the period. BNP Paribas Arbitrage SA raised its stake in Orthofix International N.V. by 68.9% during the 1st quarter. BNP Paribas Arbitrage SA now owns 4,656 shares of the medical device company’s stock worth $178,000 after buying an additional 1,900 shares during the period. Finally, Municipal Employees Retirement System of Michigan acquired a new position in Orthofix International N.V. during the 2nd quarter worth approximately $196,000. 94.40% of the stock is currently owned by institutional investors.

Orthofix International N.V. (OFIX) opened at 49.02 on Wednesday. Orthofix International N.V. has a 1-year low of $32.51 and a 1-year high of $51.09. The company’s 50-day moving average price is $48.72 and its 200-day moving average price is $44.37. The firm has a market capitalization of $890.69 million, a P/E ratio of 114.80 and a beta of 0.20.

Orthofix International N.V. (NASDAQ:OFIX) last issued its quarterly earnings data on Monday, August 7th. The medical device company reported $0.42 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 9.96%. The business had revenue of $108.90 million during the quarter, compared to analyst estimates of $102.94 million. During the same period last year, the business posted $0.41 earnings per share. Orthofix International N.V.’s quarterly revenue was up 4.6% compared to the same quarter last year. Equities research analysts expect that Orthofix International N.V. will post $1.56 earnings per share for the current fiscal year.

A number of research firms recently weighed in on OFIX. Jefferies Group LLC reaffirmed a “buy” rating and set a $55.00 price target (up from $50.00) on shares of Orthofix International N.V. in a research note on Thursday, August 10th. BidaskClub downgraded Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Zacks Investment Research raised Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $54.00 price target on the stock in a research note on Thursday, August 10th. TheStreet raised Orthofix International N.V. from a “c+” rating to a “b-” rating in a research note on Tuesday, August 8th. Finally, Ladenburg Thalmann Financial Services began coverage on Orthofix International N.V. in a research note on Wednesday, June 14th. They set a “buy” rating and a $53.25 price target on the stock. Seven equities research analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and a consensus price target of $52.75.

ILLEGAL ACTIVITY NOTICE: “Orthofix International N.V. (OFIX) Stake Lessened by Public Sector Pension investment Board” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://ledgergazette.com/2017/10/11/orthofix-international-n-v-ofix-stake-lessened-by-public-sector-pension-investment-board.html.

In other news, CFO Rice Doug sold 7,353 shares of Orthofix International N.V. stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $49.46, for a total transaction of $363,679.38. Following the completion of the transaction, the chief financial officer now directly owns 44,743 shares in the company, valued at $2,212,988.78. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Brad Mason sold 2,733 shares of Orthofix International N.V. stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $48.10, for a total transaction of $131,457.30. Following the transaction, the chief executive officer now owns 188,053 shares of the company’s stock, valued at $9,045,349.30. The disclosure for this sale can be found here. Insiders have sold 23,406 shares of company stock valued at $1,138,531 over the last quarter. Company insiders own 5.60% of the company’s stock.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply